| 产品名称: | Aspergillus fischeri var. brasiliensis Karwowski et al., anamorph |
|---|---|
| 商品货号: | TS173675 |
| Strain Designations: | AB 1826M-35 NRRL 18896 |
| Application: | produces 5-N-acetylardeemin |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Type Strain: | no |
| Preceptrol®: | no |
| Medium: | ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions: | Temperature: 37.0°C |
| Sequenced Data: | No DNA sequencing was performed in house on this product.
|
| Name of Depositor: | Abbott Labs. |
| Special Collection: | NCRR Contract |
| Chain of Custody: | ATCC < |
| Isolation: | soil, Brazil |
| References: | Kadam SK, et al. Multiple drug resistance-attenuating compounds. US Patent 5,284,947 dated Feb 8 1994 Karwowski JP, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity. J. Antibiot. 46: 374-379, 1993. PubMed: 8478255 Hochlowski JE, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners. J. Antibiot. 46: 380-386, 1993. PubMed: 8478256 |